350 related articles for article (PubMed ID: 32473620)
1. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.
Uddin MS; Kabir MT; Al Mamun A; Behl T; Mansouri RA; Aloqbi AA; Perveen A; Hafeez A; Ashraf GM
Curr Pharm Des; 2021; 27(3):357-366. PubMed ID: 32473620
[TBL] [Abstract][Full Text] [Related]
2. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.
Uddin MS; Hasana S; Ahmad J; Hossain MF; Rahman MM; Behl T; Rauf A; Ahmad A; Hafeez A; Perveen A; Ashraf GM
Curr Pharm Des; 2021; 27(3):402-414. PubMed ID: 33213314
[TBL] [Abstract][Full Text] [Related]
3. Inflammation as a central mechanism in Alzheimer's disease.
Kinney JW; Bemiller SM; Murtishaw AS; Leisgang AM; Salazar AM; Lamb BT
Alzheimers Dement (N Y); 2018; 4():575-590. PubMed ID: 30406177
[TBL] [Abstract][Full Text] [Related]
4. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
Althafar ZM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics.
Vaiserman A; Koliada A; Lushchak O
Mech Ageing Dev; 2020 Jul; 189():111259. PubMed ID: 32450086
[TBL] [Abstract][Full Text] [Related]
6. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease.
Kabir MT; Uddin MS; Zaman S; Rahman MS; Behl T; Ahmad A; Hafeez A; Perveen A; Ashraf GM
Curr Pharm Des; 2021; 27(22):2635-2647. PubMed ID: 33463452
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammatory responses in Alzheimer's disease.
Dansokho C; Heneka MT
J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
[TBL] [Abstract][Full Text] [Related]
11. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease.
Ceyzériat K; Zilli T; Millet P; Frisoni GB; Garibotto V; Tournier BB
Curr Alzheimer Res; 2020; 17(2):112-125. PubMed ID: 32129164
[TBL] [Abstract][Full Text] [Related]
12. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
[TBL] [Abstract][Full Text] [Related]
13. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
14. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
15. Role of Chemokines in the Development and Progression of Alzheimer's Disease.
Wojcieszak J; Kuczyńska K; Zawilska JB
J Mol Neurosci; 2022 Sep; 72(9):1929-1951. PubMed ID: 35821178
[TBL] [Abstract][Full Text] [Related]
16. The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease.
Palova D; Turic Csokova N; Markova K; Kontsekova E; Kovacech B; Zilkova M
Gen Physiol Biophys; 2021 Nov; 40(6):463-478. PubMed ID: 34897021
[TBL] [Abstract][Full Text] [Related]
17. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
18. Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease.
Cai HY; Yang JT; Wang ZJ; Zhang J; Yang W; Wu MN; Qi JS
Biochem Biophys Res Commun; 2018 Jan; 495(1):1034-1040. PubMed ID: 29175324
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
